This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of TherapeuticsMD Inc. shed 8.0% to $0.80 on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index falling 4.0% to 17,468.32 and Dow Jones Industrial Average falling 2.1% to 41,911.71.
TherapeuticsMD Inc. closed 69.4% short of its 52-week high of $2.61, which the company reached on March 18th.
The stock underperformed when compared to some of its competitors, as AbbVie Inc. rose 1.1% to $216.66.
Trading volume totaled 101,041, compared to the 50-day average of 682,711.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
March 10, 2025 16:33 ET (20:33 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。